DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Etofibrate
Etofibrate
FIELD Study Revealed Fenofibrate Reduced Need for Laser Treatment for Diabetic Retinopathy by Anthony C
Profile Profile Uses and Administration Adverse Effects And
Joint Assessment Report Was Discussed by the Phvwp at Its Meeting in July 2007 and Finalised in September 2007
Fenofibrate Capsules Apotex Standard 67 Mg and 200 Mg
Methods of Chromatographic Determination of Medicines Decreasing the Level of Cholesterol
Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021
2 12/ 35 74Al
Anatomical Classification Guidelines V2020 EPHMRA ANATOMICAL
Therapeutic Class Overview Fibric Acid Derivatives
Peroxisome Proliferator-Activated Receptors
(12) Patent Application Publication (10) Pub. No.: US 2002/0155091A1 Huval Et Al
Section B Changed Classes/Guidelines Final Version Date of Issue
Trends in Lipid-Modifying Agent Use in 83 Countries
Metabolic Disease
PPAR Agonists, the 2008), and Fatty Acid Translocase/CD36 (Kiens Et Al
Development of Chromatographic Method for Determination of Drugs Reducing Cholesterol Level
GSK3B Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties and Is a Novel Drug Target for Triple-Negative Breast Cancer
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Top View
Technology Road Mapping for Innovation Pathways of Fibrates: a Cross-Database Patent Review
Etofibrate but Not Controlled-Release Niacin Decreases LDL Cholesterol and Lipoprotein (A) in Type Iib Dyslipidemic Subjects
(12) United States Patent (10) Patent No.: US 6,365,186 B1 Huval Et Al
Accessibility Improving Information Using Online Patient Drug Reviews
Bioactive Compound Library Plus (96-Well)
Changes Highlighted Final Version Date of Issue
Comparative Study on the in Vivo and in Vitro Antilipolytic Effects of Etofibrate, Nicotinic Acid and Clofibrate in the Rat
Fenofibrate: a Novel Formulation (Triglide™) in the Treatment of Lipid Disorders: a Review
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Anatomical Classification Guidelines V2006A EPHMRA ANATOMICAL
The Role of Fibrates in Primary Biliary Cholangitis
Trends in Lipid-Modifying Agent Use in 83 Countries
Pharmaceutical Appendix to the Tariff Schedule 2
PPARS - Peroxisome Proliferator Activated Receptor Activators and Fibrates Actions Sidney Carvalho Fernandes1, Anita L
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
General Pharmacology and Toxicology”
Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
ICD-10-CM Table of Drugs 2019
Review Article Peroxisome Proliferator Activated Receptors and Lipoprotein Metabolism
Ivermectin Interest Group Submission
3968.Full.Pdf
Therapeutic Class Overview Fibric Acid Derivatives
Resolution Ap (2000) 1
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Ppars/Rxrs in Cardiovascular Physiology and Disease
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
MANAGING BLOOD CHOLESTEROL in ADULTS: SYSTEMATIC EVIDENCE REVIEW from the CHOLESTEROL EXPERT PANEL, 2013 Iii